Routine outcomes monitoring to support improving care for schizophrenia: report from the VA Mental Health QUERI

Alexander S Young, Noosha Niv, Matthew Chinman, Lisa Dixon, Susan V Eisen, Ellen P Fischer, Jeffrey Smith, Marcia Valenstein, Stephen R Marder, Richard R Owen, Alexander S Young, Noosha Niv, Matthew Chinman, Lisa Dixon, Susan V Eisen, Ellen P Fischer, Jeffrey Smith, Marcia Valenstein, Stephen R Marder, Richard R Owen

Abstract

In schizophrenia, treatments that improve outcomes have not been reliably disseminated. A major barrier to improving care has been a lack of routinely collected outcomes data that identify patients who are failing to improve or not receiving effective treatments. To support high quality care, the VA Mental Health QUERI used literature review, expert interviews, and a national panel process to increase consensus regarding outcomes monitoring instruments and strategies that support quality improvement. There was very good consensus in the domains of psychotic symptoms, side-effects, drugs and alcohol, depression, caregivers, vocational functioning, and community tenure. There are validated instruments and assessment strategies that are feasible for quality improvement in routine practice.

References

    1. American Diabetes Association Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27:596–601. doi: 10.2337/diacare.27.2.596.
    1. American Psychiatric Association Practice guideline for the treatment of patients with schizophrenia, second edition. American Journal of Psychiatry. 2004;161:1–56. doi: 10.1176/appi.ajp.161.1.1.
    1. Asch SM, McGlynn EA, Hogan MM, Hayward RA, Shekelle P, Rubenstein L, Keesey J, Adams J, Kerr EA. Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Annals of Internal Medicine. 2004;141:938–945.
    1. Bebout RR, Drake RE, Xie H, McHugo GJ, Harris M. Housing status among formerly homeless dually diagnosed adults. Psychiatric Services. 1997;48:936–941.
    1. Beck AT. Cognitive therapy: Past, present, and future. Journal of Consulting and Clinical Psychology. 1993;61:194–198. doi: 10.1037/0022-006X.61.2.194.
    1. Beck A, Steer R. Manual for the beck scale for suicidal ideation. San Antonio, TX: Psychological Corporation; 1991.
    1. Beck AT, Steer RA, Brown GK. Manual for the beck depression inventory. 2. San Antonio, TX: The Psychological Corporation; 1996.
    1. Bohn MJ, Babor TF, Kranzler HR. The Alcohol Use Disorders Identification Test (AUDIT): Validation of a screening instrument for use in medical settings. Journal of Studies on Alcohol. 1995;56:423–432.
    1. Brown GS, Lambert MJ, Jones ER, Minami T. Identifying highly effective psychotherapists in a managed care environment. American Journal of Managed Care. 2005;11:513–520.
    1. Brown RL, Leonard T, Saunders LA, Papasouliotis O. A two-item screening test for alcohol and other drug problems. Journal of Family Practice. 1997;44:151–160.
    1. Bryson CL, Au DH, Young B, McDonell MB, Fihn SD. A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp) Medical Care. 2007;45:497–504. doi: 10.1097/MLR.0b013e3180329368.
    1. Busch AB, Frank RG, Lehman AF. The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophrenia. Archives of General Psychiatry. 2004;61:442–448. doi: 10.1001/archpsyc.61.5.442.
    1. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Archives of Internal Medicine. 1998;158:1789–1795. doi: 10.1001/archinte.158.16.1789.
    1. Byerly MJ, Nakonezny PA, Fisher R, Magouirk B, Rush AJ. An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder. Schizophrenia Research. 2006;81:311–316. doi: 10.1016/j.schres.2005.08.013.
    1. Byerly MJ, Thompson A, Carmody T, Bugno R, Erwin T, Kashner M, Rush AJ. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatric Services. 2007;58:844–847. doi: 10.1176/appi.ps.58.6.844.
    1. Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials. American Journal of Psychiatry. 2001;158:518–526. doi: 10.1176/appi.ajp.158.4.518.
    1. Chinman M, Hassell J, Magnabosco J, Nowlin-Finch N, Marusak S, Young AS. The feasibility of computerized patient self-assessment at mental health clinics. Administration and Policy In Mental Health. 2007;34:401–409. doi: 10.1007/s10488-007-0120-4.
    1. Chinman M, Young AS, Hassell J, Davidson L. Toward the implementation of mental health consumer provider services. Journal of Behavioral Health Services and Research. 2006;33:176–195. doi: 10.1007/s11414-006-9009-3.
    1. Chinman M, Young AS, Schell T, Hassell J, Mintz J. Computer-assisted self-assessment in persons with severe mental illness. Journal of Clinical Psychiatry. 2004;65:1343–1351. doi: 10.4088/JCP.v65n1008.
    1. Clark A, Friedman MJ. Factor structure and discriminant validity of the SCL-90 in a veteran psychiatric population. Journal of Personality Assessment. 1983;47:396–404. doi: 10.1207/s15327752jpa4704_10.
    1. Cole JD, Kazarian SS. The Level of Expressed Emotion Scale: A new measure of expressed emotion. Journal of Clinical Psychology. 1988;44:392–397. doi: 10.1002/1097-4679(198805)44:3<392::AID-JCLP2270440313>;2-3.
    1. Covell NH, Jackson CT, Evans AC, Essock SM. Antipsychotic prescribing practices in Connecticut’s public mental health system: Rates of changing medications and prescribing styles. Schizophrenia Bulletin. 2002;28:17–29.
    1. Cramer JA. Overview of methods to measure and enhance patient compliance. In: Cramer JA, Spilker B, editors. Patient compliance in medical practice and clinical trials. New York, NY: Raven Press; 1991.
    1. Crowther RE, Marshall M, Bond GR, Huxley P. Helping people with severe mental illness to obtain work: Systematic review. BMJ. 2001;322:204–208. doi: 10.1136/bmj.322.7280.204.
    1. Cuffel BJ, Fischer EP, Owen RR, Jr, Smith GR., Jr An instrument for measurement of outcomes of care for schizophrenia. Issues in development and implementation. Evaluation and the Health Professions. 1997;20:96–108. doi: 10.1177/016327879702000107.
    1. Dawe S, Seinen A, Kavanagh D. An examination of the utility of the AUDIT in people with schizophrenia. Journal of Studies on Alcohol. 2000;61:744–750.
    1. Dawson DA, Grant BF, Stinson FS, Zhou Y. Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population. Alcoholism, Clinical and Experimental Research. 2005;29:844–854. doi: 10.1097/01.ALC.0000164374.32229.A2.
    1. Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C. Attitudes toward antipsychotic medication: The impact of clinical variables and relationships with health professionals. Archives of General Psychiatry. 2005;62:717–724. doi: 10.1001/archpsyc.62.7.717.
    1. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: An introductory report. Psychological Medicine. 1983;13:595–605. doi: 10.1017/S0033291700048017.
    1. Eisen SV, Normand SL, Belanger AJ, Spiro A, III, Esch D. The Revised Behavior and Symptom Identification Scale (BASIS-R): Reliability and validity. Medical Care. 2004;42:1230–1241. doi: 10.1097/00005650-200412000-00010.
    1. Fihn SD, McDonell MB, Diehr P, Anderson SM, Bradley KA, Au DH, Spertus JA, Burman M, Reiber GE, Kiefe CI, Cody M, Sanders KM, Whooley MA, Rosenfeld K, Baczek LA, Sauvigne A. Effects of sustained audit/feedback on self-reported health status of primary care patients. American Journal of Medicine. 2004;116:241–248. doi: 10.1016/j.amjmed.2003.10.026.
    1. Fitch K, Bernstein S, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, Van het Loo M, McDonnell J, Vader JP, Kahan JP. The RAND/UCLA appropriateness method user’s manual. Santa Monica, CA: RAND; 2001.
    1. Francis J, Perlin JB. Improving performance through knowledge translation in the Veterans Health Administration. The Journal of Continuing Education in the Health Professions. 2006;26:63–71. doi: 10.1002/chp.52.
    1. Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, Jeste DV. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry. 2004;161:692–699. doi: 10.1176/appi.ajp.161.4.692.
    1. Gorall DM, Tiesel J, Olson DH. FACES-IV: Development and validation. Minneapolis, MN: Life Innovations; 2004.
    1. Hays RD, Wells KB, Sherbourne CD, Rogers W, Spritzer K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Archives of General Psychiatry. 1995;52:11–19.
    1. Hoe M, Brekke J. Testing the cross-ethnic construct validity of the Brief Symptom Inventory. Research on Social Work Practice. 2009;19:93–103. doi: 10.1177/1049731508317285.
    1. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychological Medicine. 1983;13:177–183. doi: 10.1017/S0033291700050182.
    1. Institute of Medicine . Improving the quality of health care for mental and substance-use conditions: Quality chasm series. Washington, DC: National Academies Press; 2006.
    1. Jha AK, Perlin JB, Kizer KW, Dudley RA. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. New England Journal of Medicine. 2003;348:2218–2227. doi: 10.1056/NEJMsa021899.
    1. Kane JM, Marder SR. Schizophrenia: Somatic treatment. In: Sadock BJ, Sadock VA, editors. Kaplan & Sadock’s comprehensive textbook of psychiatry. New York, NY: Lippincott Williams & Wilkins; 2005. pp. 1467–1476.
    1. Kavanagh DJ, O’Halloran P, Manicavasagar V, Clark D, Piatkowska O, Tennant C, Rosen A. The Family Attitude Scale: Reliability and validity of a new scale for measuring the emotional climate of families. Psychiatry Research. 1997;70:185–195. doi: 10.1016/S0165-1781(97)00033-4.
    1. Kreisman DE, Simmens SJ, Joy VD. Rejecting the patient: Preliminary validation of a self-report scale. Schizophrenia Bulletin. 1979;5:220–222.
    1. Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB. The schizophrenia patient outcomes research team (PORT): Updated treatment recommendations 2009. Schizophrenia Bulletin. 2010;36:94–103. doi: 10.1093/schbul/sbp130.
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Kupersmith J, Francis J, Kerr E, Krein S, Pogach L, Kolodner RM, Perlin JB. Advancing evidence-based care for diabetes: Lessons from the Veterans Health Administration. Health Affairs. 2007;26:w156–w168. doi: 10.1377/hlthaff.26.2.w156.
    1. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. Journal of Clinical Psychiatry. 2002;63:892–909.
    1. Law MR, Soumerai SB, Ross-Degnan D, Adams AS. A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. Journal of Clinical Psychiatry. 2008;69:47–53. doi: 10.4088/JCP.v69n0107.
    1. Lehman AF. A quality of life interview for the chronically mentally ill. Evaluation and Program Planning. 1988;11:51–62. doi: 10.1016/0149-7189(88)90033-X.
    1. Lehman AF. Quality of care in mental health: The case of schizophrenia. Health Affairs. 1999;18:52–65. doi: 10.1377/hlthaff.18.5.52.
    1. Leslie DL, Rosenheck R. Eighth annual report on schizophrenia pharmacotherapy in VA (FY 2006) New Haven, CT: Northeast Program Evaluation Center, US Department of Veterans Affairs; 2007.
    1. Lowe B, Unutzer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Medical Care. 2004;42:1194–1201. doi: 10.1097/00005650-200412000-00006.
    1. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT, Jr, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S. Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry. 2004;161:1334–1349. doi: 10.1176/appi.ajp.161.8.1334.
    1. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: Validation of a new alcoholism screening instrument. American Journal of Psychiatry. 1974;131:1121–1123.
    1. McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA, Swartz MS, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. American Journal of Psychiatry. 2006;163:600–610. doi: 10.1176/appi.ajp.163.4.600.
    1. McFarlane WR, Dushay RA, Deakins SM, Stastny P, Lukens EP, Toran J, Link B. Employment outcomes in family-aided assertive community treatment. The American Journal of Orthopsychiatry. 2000;70:203–214. doi: 10.1037/h0087819.
    1. McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, Manber R. The Arizona Sexual Experience Scale (ASEX): Reliability and validity. Journal of Sex and Marital Therapy. 2000;26:25–40. doi: 10.1080/009262300278623.
    1. McHugo GJ, Bebout RR, Harris M, Cleghorn S, Herring G, Xie H, Becker D, Drake RE. A randomized controlled trial of integrated versus parallel housing services for homeless adults with severe mental illness. Schizophrenia Bulletin. 2004;30:969–982.
    1. McHugo GJ, Paskus TS, Drake RE. Detection of alcoholism in schizophrenia using the MAST. Alcoholism, Clinical and Experimental Research. 1993;17:187–191. doi: 10.1111/j.1530-0277.1993.tb00746.x.
    1. McQueen L, Mittman BS, Demakis JG. Overview of the veterans health administration (VHA) Quality Enhancement Research Initiative (QUERI) Journal of the American Medical Informatics Association. 2004;11:339–343. doi: 10.1197/jamia.M1499.
    1. Miller IW, Epstein NB, Bishop DS, Keitner GI. The McMaster Family Assessment Device: Reliability and validity. Journal of Marital and Family Therapy. 1985;11:345–356. doi: 10.1111/j.1752-0606.1985.tb00028.x.
    1. Miller AL, Hall CS, Buchanan RW, Buckley PF, Chiles JA, Conley RR, Crismon ML, Ereshefsky L, Essock SM, Finnerty M, Marder SR, Miller DD, McEvoy JP, Rush AJ, Saeed SA, Schooler NR, Shon SP, Stroup S, Tarin-Godoy B. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. Journal of Clinical Psychiatry. 2004;65:500–508. doi: 10.4088/JCP.v65n0408.
    1. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care. 1986;24:67–74. doi: 10.1097/00005650-198601000-00007.
    1. Morlan KK, Tan SY. Comparison of the brief psychiatric rating scale and the brief symptom inventory. Journal of Clinical Psychology. 1998;54:885–894. doi: 10.1002/(SICI)1097-4679(199811)54:7<885::AID-JCLP3>;2-E.
    1. Newcomer JW. Antipsychotic medications: Metabolic and cardiovascular risk. Journal of Clinical Psychiatry. 2007;68(Suppl 4):8–13.
    1. Newcomer JW, Campos JA, Marcus RN, Breder C, Berman RM, Kerselaers W, L’Italien GJ, Nys M, Carson WH, McQuade RD. A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine. Journal of Clinical Psychiatry. 2008;69:1046–1056. doi: 10.4088/JCP.v69n0702.
    1. Niv N, Cohen AN, Mintz J, Ventura J, Young AS. The validity of using patient self-report to assess psychotic symptoms in schizophrenia. Schizophrenia Research. 2007;90:245–250. doi: 10.1016/j.schres.2006.11.011.
    1. Niv N, Cohen AN, Sullivan G, Young AS. The MIRECC version of the Global Assessment of Functioning Scale: Reliability and validity. Psychiatric Services. 2007;58:529–535. doi: 10.1176/appi.ps.58.4.529.
    1. Osterberg L, Blaschke T. Adherence to medication. New England Journal of Medicine. 2005;353:487–497. doi: 10.1056/NEJMra050100.
    1. Pfeffer CR, Newcorn J, Kaplan G, Mizruchi MS, Plutchik R. Suicidal behavior in adolescent psychiatric inpatients. Journal of the American Academy of Child and Adolescent Psychiatry. 1988;27:357–361. doi: 10.1097/00004583-198805000-00015.
    1. Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Orbach G, Morgan C. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine. 2002;32:763–782.
    1. Pinninti N, Steer RA, Rissmiller DJ, Nelson S, Beck AT. Use of the Beck Scale for suicide ideation with psychiatric inpatients diagnosed with schizophrenia, schizoaffective, or bipolar disorders. Behaviour Research and Therapy. 2002;40:1071–1079. doi: 10.1016/S0005-7967(02)00002-5.
    1. Pitschel-Walz G, Leucht S, Bauml J, Kissling W, Engel RR. The effect of family interventions on relapse and rehospitalization in schizophrenia—A meta-analysis. Schizophrenia Bulletin. 2001;27:73–92.
    1. President’s New Freedom Commission on Mental Health. (2003). Achieving the promise: Transforming mental health care in America.. Accessed 7 May 2009.
    1. Preston NJ, Harrison TJ. The brief symptom inventory and the positive and negative syndrome scale: Discriminate validity between a self-reported and observational measure of psychopathology. Comprehensive Psychiatry. 2003;44:220–226. doi: 10.1016/S0010-440X(03)00010-5.
    1. Rauter UK, Leonard CE, Swett CP. SCL-90-R factor structure in an acute, involuntary, adult psychiatric inpatient sample. Journal of Clinical Psychology. 1996;52:625–629. doi: 10.1002/(SICI)1097-4679(199611)52:6<625::AID-JCLP4>;2-J.
    1. Resnick SG, Bond GR. The Indiana Job Satisfaction Scale: Job satisfaction in vocational rehabilitation for people with severe mental illness. Psychiatric Rehabilitation Journal. 2001;25:12–19.
    1. Resnick SG, Rosenheck RA, Dixon L, Lehman AF. Correlates of family contact with the mental health system: Allocation of a scarce resource. Mental Health Services Research. 2005;7:113–121. doi: 10.1007/s11020-005-3782-0.
    1. Rubenstein LV, Mittman BS, Yano EM, Mulrow CD. From understanding health care provider behavior to improving health care: The QUERI framework for quality improvement. Quality Enhancement Research Initiative. Medical Care. 2000;38:I.129–I.141. doi: 10.1097/00005650-200006001-00013.
    1. Russell M. New assessment tools for risk drinking during pregnancy: T-ACE, TWEAK, and others. Alcohol Health & Research World. 1994;18:55–61.
    1. Russell M, Bigler L. Screening for alcohol-related problems in an outpatient obstetric-gynecologic clinic. American Journal of Obstetrics and Gynecology. 1979;134:4–12.
    1. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption—II. Addiction. 1993;88:791–804. doi: 10.1111/j.1360-0443.1993.tb02093.x.
    1. Schooler N, Hogarty G, Weissman MM. Social Adjustment Scale II (SAS-II) In: Hargreaves WA, Attkisson CC, Sorenson JE, editors. Resource materials for community health program evaluators. Washington, DC: US Department of Health, Education and Welfare; 1979.
    1. Selzer ML. The Michigan alcoholism screening test: The quest for a new diagnostic instrument. American Journal of Psychiatry. 1971;127:1653–1658.
    1. Skinner HA. The drug abuse screening test. Addictive Behaviors. 1982;7:363–371. doi: 10.1016/0306-4603(82)90005-3.
    1. Staley D, El-Guebaly N. Psychometric properties of the drug abuse screening test in a psychiatric patient population. Addictive Behaviors. 1990;15:257–264. doi: 10.1016/0306-4603(90)90068-9.
    1. Stone EG, Morton SC, Hulscher ME, Maglione MA, Roth EA, Grimshaw JM, Mittman BS, Rubenstein LV, Rubenstein LZ, Shekelle PG. Interventions that increase use of adult immunization and cancer screening services: A meta-analysis. Annals of Internal Medicine. 2002;136:641–651.
    1. Toland AM, Moss HB. Identification of the alcoholic schizophrenic: Use of clinical laboratory tests and the MAST. Journal of Studies on Alcohol. 1989;50:49–53.
    1. Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care. 2002;40:630–639. doi: 10.1097/00005650-200208000-00002.
    1. Ventura J, Green MF, Shaner A, Liberman RP. Training and quality assurance with the Brief Psychiatric Rating Scale: “The drift busters”. International Journal of Methods in Psychiatric Research. 1993;3:221–244.
    1. Veterans Health Administration. (2003). VA technology assessment program (VATAP) Short report: Outcomes measurement in schizophrenia. Number 2 in a series: Outcomes measurement in VHA mental health services. . Accessed 11 May 2009.
    1. Weiden PJ, Kozma C, Grogg A, Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services. 2004;55:886–891. doi: 10.1176/appi.ps.55.8.886.
    1. WHO ASSIST Working Group The alcohol, smoking and substance involvement screening test (ASSIST): Development, reliability and feasibility. Addiction. 2002;97:1183–1194. doi: 10.1046/j.1360-0443.2002.00185.x.
    1. Wolford GL, Rosenberg SD, Drake RE, et al. Evaluation of methods for detecting substance use disorder in persons with severe mental illness. Psychol Addict Behav. 1999;13:313–326. doi: 10.1037/0893-164X.13.4.313.
    1. Young AS. Evaluating and improving the appropriateness of treatment for schizophrenia. Harvard Review of Psychiatry. 1999;7:114–118.
    1. Young AS. Routinely measuring schizophrenia treatment quality—Shortcomings with medical records. Medical Care. 2007;45:104. doi: 10.1097/01.mlr.0000250261.86922.06.
    1. Young AS, Magnabosco JL. Services for adults with mental illness. In: Levin BL, Petrila J, Hennessy KD, editors. Mental health services: A public health perspective. New York, NY: Oxford University Press; 2004. pp. 177–208.
    1. Young AS, Mintz J, Cohen AN. Using information systems to improve care for persons with schizophrenia. Psychiatric Services. 2004;55:253–255. doi: 10.1176/appi.ps.55.3.253.
    1. Young AS, Sullivan G, Burnam MA, Brook RH. Measuring the quality of outpatient treatment for schizophrenia. Archives of General Psychiatry. 1998;55:611–617. doi: 10.1001/archpsyc.55.7.611.
    1. Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry. 2002;159:1653–1664. doi: 10.1176/appi.ajp.159.10.1653.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit